EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

MicroRNA Signatures in Cardiometabolic Disorders as a Next-Generation Diagnostic Approach: Current Insight

Concetta Iside, Francesca Picone iD, Paola Di Pietro iD, Angela Carmelita Abate iD, Valeria Prete iD, Antonio Damato iD, Eleonora Venturini, Saad Akeel iD, Salvatore Petralia iD, Carmine Vecchione, Albino Carrizzo iD

International Journal of Molecular Sciences · 05.11.2025 · 26 (21) · 10769

DOI: 10.3390/ijms262110769 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.11.2025. Verfasst von Concetta Iside und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy. Hauptthemen laut MEDLINE: Cardiovascular Diseases, MicroRNAs, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MASE_regione campania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiometabolic diseases, including cardiovascular disorders and type 2 diabetes mellitus, are the leading cause of morbidity and mortality worldwide, placing a significant burden on healthcare systems. Although advances in imaging and risk stratification have improved disease management, conventional diagnostic and prognostic tools often lack the requisite sensitivity and specificity for early and precise risk stratification. This limitation stems from their poor ability to capture the full molecular complexity of these conditions, underscoring an urgent need for innovative biomarkers to bridge these gaps. MicroRNAs, small non-coding RNAs that regulate gene expression post-transcriptionally, have emerged as promising candidates. Their characteristics offer several advantages over traditional methods, including exceptional stability in biological fluids, strong tissue and disease specificity, and the ability to reflect dynamic pathological changes. These unique features enable miRNAs to detect subtle molecular alterations that may precede clinical symptoms, thereby overcoming key limitations of current diagnostic approaches. Altered circulating miRNA profiles have been linked to pathological processes such as endothelial dysfunction, inflammation, oxidative stress, and maladaptive cardiac remodeling. This review provides a comprehensive overview of the current evidence supporting the diagnostic and prognostic role of circulating miRNAs in cardiometabolic disease. We highlight their potential as early detection biomarkers, tools for patient stratification, and indicators of therapeutic response. Furthermore, we discuss key limitations to clinical translation, including methodological variability, challenges in sample handling, differences in normalization strategies, and platform-dependent quantification inconsistencies. Overcoming these obstacles and achieving robust large-scale clinical validation will be essential to fully harness the potential of miRNAs as next-generation molecular signatures in precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMicroRNAsDiabetes Mellitus, Type 2HumansBiomarkersAnimalsPrognosis

Stichwörter der Autor:innen

biomarkerscardiovascular diseasediabetesdiagnostic discoverymiRNA

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.
  • Vascular Physiopathology Unit, IRCCS Neuromed, 86077 Pozzilli, Italy.
  • Department of Drug and Health Sciences, University of Catania, Via Santa Sofia 64, 95125 Catania, Italy.

ORCID-Profile: Francesca Picone, Paola Di Pietro, Angela Carmelita Abate, Valeria Prete, Antonio Damato, Saad Akeel, Salvatore Petralia, Albino Carrizzo

Förderung

  • MASE_regione campania

Zitieren

APA

Iside, C., Picone, F., Di Pietro, P., Abate, A. C., Prete, V., Damato, A., Venturini, E., Akeel, S., Petralia, S., Vecchione, C., & Carrizzo, A. (2025). MicroRNA Signatures in Cardiometabolic Disorders as a Next-Generation Diagnostic Approach: Current Insight. International Journal of Molecular Sciences, 26(21), 10769. https://doi.org/10.3390/ijms262110769

Vancouver

Iside C, Picone F, Di Pietro P, Abate AC, Prete V, Damato A, et al. MicroRNA Signatures in Cardiometabolic Disorders as a Next-Generation Diagnostic Approach: Current Insight. International Journal of Molecular Sciences. 2025;26(21):10769. doi:10.3390/ijms262110769

BibTeX
@article{Iside2025,
  author = {Iside, Concetta and Picone, Francesca and Di Pietro, Paola and Abate, Angela Carmelita and Prete, Valeria and Damato, Antonio and Venturini, Eleonora and Akeel, Saad and Petralia, Salvatore and Vecchione, Carmine and Carrizzo, Albino},
  title = {MicroRNA Signatures in Cardiometabolic Disorders as a Next-Generation Diagnostic Approach: Current Insight},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10769},
  doi = {10.3390/ijms262110769}
}
Kostenlos starten →